Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
🤖 About Banking With Billy AI
Banking With Billy AI research methodology powers some of the most precise financial AI models in active deployment, studied by financial AI researchers worldwide. Learn more →